Skip to main content

Table 2 Results of esophagogastroduodenoscopy in the enrolled patients

From: Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer

Patient number Sex Age range
(years)
Sedation Location Histologic diagnosis using EGD forceps Complication Passage of scope Number of biopsied tissue fragments Concomitant upper gastrointestinal disease
00298963 male 65–70 + posterior pharyngeal wall and pyriform sinus no yes 0 reflux esophagitis, gastric polyp, duodenal ulcer active stage
00298607 male 60–65 pyriform sinus squamous cell carcinoma no yes 4 atrophic gastritis, intestinal metaplasia
00272563 male 60–65 pyriform sinus squamous cell carcinoma no yes 3 duodenal polyp
00164374 male 75–80 + pyriform sinus squamous cell carcinoma no yes 3 atrophic gastritis, intestinal metaplasia
00294335 male 85–90 + pyriform sinus a few necrotic atypical squamous cells no noa 3 atrophic gastritis, intestinal metaplasia
00252398 male 50–55 + postcricoid area squamous cell carcinoma no yes 2 Gastric ulcer scar
00247856 male 80–85 + posteriorpharyngeal wall squamous cell carcinoma no yes 3  
00225664 male 60–65 posterior pharyngeal wall no yes 0 esophageal candidiasis
00176506 male 75–80 posterior pharyngeal wall/postcricoid area no no 0  
  1. EGD esophagogastroduodenoscopy, aUltrathin scope passed through the pyriform sinus